Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 157   

Articles published

MRK 56.47 +0.21 (0.37%)
price chart
Will Merck & Co. Inc Unseat Biotech's Hottest Drug?
Merck's combination hep C therapy of drugs MK-5172 and MK-8742 scored a 98% cure rate in a recent mid-stage trial, and the company's hoping for a victory in its currently underway phase 3 trial for the treatment as well. Can Merck emerge as an ...
Drugmaker Studies Find a Bargain in $84000 Medicine  Bloomberg
Related articles »  
Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences ...
While leader Gilead Sciences (NASDAQ: GILD ) waits on the FDA review for its combination of Sovaldi and levipasvir, and battles questions over Sovaldi's price tag, Merck is producing data on easy-to-treat populations and Bristol-Myers Squibb has turned ...
Related articles »  
Merck & Co., Inc. (NYSE:MRK) Reports Positives on its Hepatitis Treatment
Dallas, Texas 04/11/2014 (ustradevoice) - Merck & Co., Inc. (NYSE:MRK) continues to surge in the market after the company announced positive news, on the progress being made on the development of its hepatitis C combo therapies MK-5172 AND ...
Merck Hepatitis C combo pill impresses in Phase II  Seeking Alpha
Merck Data Show Potent Rival to Gilead's Hepatitis C Pill  Bloomberg
Related articles »  
Stocks to Watch Friday: Merck & Co., Inc., Deere & Company, and Toyota Motor ...
Momentum names that made notable moves on Thursday and could continue to do so into Friday's session include pharmaceutical firm Merck & Co., Inc. (NYSE:MRK), machinery concern Deere & Company (NYSE:DE), and automaker Toyota Motor Corp ...
Merck & Co. Price Target Increased to $70.00 by Analysts at MKM Partners ...  Ticker Report
Drug Most active stocks: Pfizer Inc. (NYSE:PFE), Merck & Co (NYSE:MRK ...  Gaining Green
Related articles »  
One Put, One Call Option To Know About For Merck & Co.
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Merck & Co., Inc (MRK). So this week we highlight one interesting put contract, and one interesting call contract, from the May ...
Related articles »  
Brand Face-Off: GlaxoSmithKline plc (ADR) vs. Merck & Co., Inc.
Pharmaceutical giants GlaxoSmithKline plc (ADR) (NYSE:GSK) and Merck & Co., Inc. (NYSE:MRK) have charted different paths during the last year.
Insider Selling: Merck & Co. Insider Unloads 145225 Shares of Stock (MRK)  Ticker Report
Related articles »  
Merck & Co., Inc. (NYSE:MRK)'s Oncology Break-Through MK-3475 Said To ...
It is the case with the breakthrough drug from Merck & Co., Inc. (NYSE:MRK) called the MK-3475 that provides efficient results in the treatment of non-small cell lung cancer (NSCLC).
Related articles »  
Stocks Buzz - Centene Corp (NYSE:CNC), Merck & Co., Inc (NYSE:MRK), Endo ...
Merck & Co., Inc (NYSE:MRK) recently declared interim results from the ongoing C-WORTHy study, a multi-arm Phase 2 clinical trial evaluating the efficacy and safety of an all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C ...
Related articles »  
Merck & Co., Inc. (NYSE:MRK) Presents Immunotherapy Findings; Collaborates ...
Boston, MA 04/07/2014 (wallstreetpr) - Yesterday, Merck & Co., Inc. (NYSE:MRK) provided early discoveries associated with the relation between PD-L1 Expression and the clinical outcome of its under study Anti-PD-1 Immunotherapy, MK-3475 at AACR ...
Related articles »  
Merck: Is The Dow's YTD Leader A Long-Term Buy?
Merck & Co., Inc. (MRK) is one of the world's largest pharmaceutical companies in the world that develops prescription medicines, vaccines, and consumer care products.